More than two-thirds of cervical cancer deaths ‘can be prevented by screening’

A new study has demonstrated that the majority of cervical cancer deaths can be successfully prevented through routine screening for the disease.

Conducted by Cancer Research UK, the study analysed the records of more than 11,000 women in England who had been diagnosed with cervical cancer. Currently, 800 women die from cervical cancer each year, but this research suggests that without screening, an additional 1,827 more women would die annually.

Overall, it is estimated that cervical screening prevents 70 percent of cervical cancer deaths, and if all eligible women regularly attended screening, this would rise to 83 per cent, or an extra 347 lives saved each year.

The biggest impact of screening is among women aged between 50 and 64 who would be five times more likely to die from cervical cancer if there were no screening.

Professor Peter Sasieni, lead researcher at Queen Mary University of London, said: "The cervical screening programme already prevents thousands of cancers each year and as it continues to improve, by testing all samples for the human papillomavirus, even more women are likely to avoid this disease."

Cervical cancer screening is offered in the UK to women aged between 25 and 64, inviting women every three years between the ages of 25 and 49, and then every five years after this until they reach age 64.

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.